Skip to content

A randomized controlled trial for the traditional Chinese medicine comprehensive antihypertensive ABC regimen in the treatment of grade-1 low- and intermediate-risk hypertension

A randomized controlled trial for the traditional Chinese medicine comprehensive antihypertensive ABC regimen in the treatment of grade-1 low- and intermediate-risk hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024159
Enrollment
Unknown
Registered
2019-06-28
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential hypertension

Interventions

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18-65 years old, male or female; (2) Diagnose with grade-1 essential hypertension, and the risk stratification is low-risk or intermediate-risk; (3) The diagnosis of TCM syndrome is liver-yang syndrome or asthenic yin causing predominant yang syndrome, or no obvious syndrome; (4) Those who have not taken antihypertensive drugs or have taken antihypertensive drugs irregularly, and do not want to take antihypertensive drugs in the next three months; (5) Subjects are volunteered to participate in the trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Obvious liver and kidney dysfunction. ALT, AST, BUN or creatinine is more than 2 times higher than normal; (2) Those who cannot operate Baduanjin or acupoint massage independently; (3) Those who have eczema or injury in head, neck or ear, which may be unsuitable for acupoint massage; (4) Chronic gastrointestinal diseases; (5) Those who may have poor compliance and failure to follow up on time; (6) Woman during pregnancy or lactation or those who have a recent birth plan; (7) Patients with severe mental illness, malignant tumors or other major diseases; (8) Those with a reversed lifestyle or irregular sleep pattern; (9) Those who are known or suspected to be allergic to the test drug; (10) Those who practice traditional Chinese exercises (such as Taijiquan, Ba Duanjin, etc.) in the past 3 months; (11) Those who are inappropriate to participate in this research.

Design outcomes

Primary

MeasureTime frame
24 hours average blood pressure;

Secondary

MeasureTime frame
office blood pressure;Compliance rate of office blood pressure;home blood pressure;daytime mean systolic blood pressure (dSBP), nighttime mean systolic blood pressure (nSBP),;24-hour average heart rate;WHOQOL-BREF score;Symptom score of hypertension grading quantization table;

Countries

China

Contacts

Public ContactHao Xu

Xiyuan Hospital, China Academy of Chinese Medical Sciences

xuhaotcm@hotmail.com+86 18601081161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026